Conversely, reduction of CCL5 expression through either CRISPR-Cas9 (BM1 cells) or CRISPR-dCas9-KRAB (LMB cells) (Figure 4C) decreased TEM-mediated tumor cell invasion (Figure 5B). The gene discussed is CCL5; the disease is neoplasm.